World TB Day collection

Elsevier

Although the number of deaths worldwide from tuberculosis—a disease caused by the bacterium Mycobacterium tuberculosis—fell by 22% between 2000 and 2015, it remains humanity’s biggest infectious killer and one of the top ten causes of all deaths. The 2016 WHO Global Tuberculosis Report estimated that in 2015 there were 10.4 million new tuberculosis cases and 1.4 million deaths. The interaction between tuberculosis and HIV is important, with an estimated 400 000 additional deaths occurring among people with co-infection. Perhaps most troubling, is that the new cases of tuberculosis include about 480 000 people with the multidrug-resistant form of the disease—that is, resistant to treatment with two of the first-line medications against tuberculosis, isoniazid and rifampicin. Only about 20% of people newly eligible for treatment for multidrug-resistant tuberculosis in 2015 were enrolled in treatment. One of the UN Sustainable Development Goals for 2030 is a 90% reduction in tuberculosis deaths and 80% reduction in new cases (incidence) compared with 2015. However, the current annual rate of decline of incidence is only 1.5% and needs to reach 4–5% for the milestone to be achieved. Furthermore, unless investment in tuberculosis treatment and prevention increases, there will be a US$6 billion funding gap by 2020. Tuberculosis remains a treatable disease—even the multidrug-resistant form, albeit with a complex and time-consuming drug regimen. Although it is primarily a disease of poor and disadvantaged people, everyone on Earth is potentially at risk of tuberculosis. World TB Day is an opportunity to highlight the challenges—and opportunities—to achieve the goal of controlling tuberculosis through sustained prevention, detection, and treatment.

March 24, 2017
Year of publication
2017
Resource types
Journal and research articles
Tags
TB, tuberculosis, TB-HIV co-infection, multidrug-resistant TB (MDR-TB), treatment, TB prevention, World TB Day

Similar Resources

Tuberculosis disproportionately affects hard-to-reach populations, such as homeless people, migrants, refugees, prisoners, or drug users. These people often face challenges in accessing quality health care.

The Southern African HIV Clinicians Society’s biannual conference, held in Johannesburg, South Africa, from 24-27 October 2018, focused on clinical content for HIV and TB health care workers in the region and featured a wide range of topics…

This study aimed to evaluate the impact of clinic-based prevention of mother-to-child transmission (PMTCT) community support by trained lay health workers in addition to standard clinical care on PMTCT infant outcomes.

As test and treat rolls out, effective interventions are needed to address the determinants of outcomes across the HIV treatment continuum and ensure that people infected with HIV are promptly tested, initiate treatment early, adhere to treatment, and are virally suppressed.

Adolescents newly diagnosed with HIV need to be rapidly incorporated into HIV care networks to have the best chances of remaining in care in the long term, research from the United States published in the June 1st edition of the Journal of Acquired Immune Deficiency Syndromes shows.

BACKGROUND:

Attrition along the HIV care continuum slows gains in mitigating the South African HIV epidemic. Understanding population-level gaps in HIV identification, linkage, retention in care and viral suppression is critical to target programming.

The much-discussed HIV ‘cascade of care’ has demonstrated marked loss between HIV diagnosis, linkage and initiation of antiretroviral treatment (ART), compromising mortality and morbidity benefits to the individual, as well as public health prevention impact.

Achieving the promise of antiretroviral therapy (ART) to reduce HIV-associated mortality and transmission in sub-Saharan Africa relies on increasing behavioral change toward earlier engagement and sustained retention in HIV care after HIV diagnosis. Health communication may be an…

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.